The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Toward personalized treatment for gastroesophageal adenocarcinoma (GEC): Strategies to address tumor heterogeneity—PANGEA.
Daniel Virgil Thomas Catenacci
No relevant relationships to disclose
Blase N. Polite
No relevant relationships to disclose
Les Henderson
No relevant relationships to disclose
Peng Xu
No relevant relationships to disclose
Brittany Rambo
No relevant relationships to disclose
Wei-Li Liao
Employment or Leadership Position - OncoPlex Dx
Todd A. Hembrough
Employment or Leadership Position - OncoPlex Dx
Lei Zhao
No relevant relationships to disclose
Shu-Yuan Xiao
No relevant relationships to disclose
John Hart
No relevant relationships to disclose
Theodore Karrison
No relevant relationships to disclose
James J. Dignam
No relevant relationships to disclose
Hedy Lee Kindler
No relevant relationships to disclose